Singapore, Jul 2, 2009: Japanese drug maker, Daiichi Sankyo renamed two Chinese subsidiaries that previously operated as Daiichi Pharmaceutical Beijing Limited and Shanghai Sankyo Pharmaceuticals Limited.

Daiichi Pharmaceutical Beijing is renamed as Daiichi Sankyo Pharmaceutical Beijing (DSBJ) and Shanghai Sankyo Pharmaceuticals as Daiichi Sankyo Pharmaceutical Shanghai (DSSH).

According to the company, the renaming is part of ongoing efforts by the Daiichi Sankyo Group to create a unified and consistent global brand.

DSBJ is established in May 1998 and it has a capitalization of $63.8 million. DSSH has a capitalization of $53 million and is established in November 1999.